Medical Sleep Monitoring From Home
Untreated sleep apnea patients suffer from a multitude of symptoms during the day and the night, such as loud snoring, sleepiness, irritability, headaches, insomnia and difficulties concentrating. These issues lead to productivity loss and increase for example the risk of car accidents. Moreover, unmanaged sleep disorders put patients in danger of developing hypertension, obesity, heart disease, depression or even strokes. This affects not only the health and wellbeing of the people affected by sleep disorders, but also creates a significant economic burden on employers and healthcare systems.
Sleepiz develops the hard- and software for a sleep disorder screening device that allows patients to get tested in the comfort of their own home. By using wireless technology, the device can measure vital human signs at medical accuracy without touching the patient. With Sleepiz’ solution the monitoring and screening can be done without any cables or wires within the patient’s home – thereby increasing comfort for the patient and reducing the workload of the clinician.
“We want more people to have access to sleep screening and diagnoses.” – Soumya Dash
The touchless device uses millimeter wave technology to capture vital signs and sleep environment data with very high accuracy and sends this data to the clinician in real-time. In order to provide a time-efficient solution, Sleepiz uses artificial intelligence to interpret the sleep patterns with medical grade accuracy. The cloud-based solution saves time and money, making sleep screening and diagnosis accessible to a greater number of patients.
The Zurich based startup was founded in the beginning of 2018 by three graduates from ETH Zurich and one graduate from the University of St. Gallen (HSG). After two successful pilot studies with their minimum viable product Sleepiz has partnered up with large hospitals and world-renowned research institutions in Switzerland.In the next three years, the founders plan on entering the sleep apnea diagnosis market starting with Switzerland and Germany. At a later stage they want to tap into other selected European and Asian markets.